Heron Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Heron Therapeutics's estimated annual revenue is currently $42.2M per year.
- Heron Therapeutics's estimated revenue per employee is $193,750
- Heron Therapeutics's total funding is $224M.
Employee Data
- Heron Therapeutics has 218 Employees.
- Heron Therapeutics grew their employee count by -30% last year.
Heron Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP - Oncology Marketing | Reveal Email/Phone |
3 | VP, Manufacturing & Supply | Reveal Email/Phone |
4 | VP Marketing - Acute Care Franchise | Reveal Email/Phone |
5 | VP, Quality Assurance | Reveal Email/Phone |
6 | VP, Chief Accounting Officer | Reveal Email/Phone |
7 | SVP Human Resources | Reveal Email/Phone |
8 | Executive Director, Packaging & Device Manufacturing | Reveal Email/Phone |
9 | Director, Finance Operations | Reveal Email/Phone |
10 | Director, Brand Marketing | Reveal Email/Phone |
Heron Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Heron Therapeutics?
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
keywords:N/A
$224M
Total Funding
218
Number of Employees
$42.2M
Revenue (est)
-30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Heron Therapeutics News
Zacks: Brokerages Expect Heron Therapeutics, Inc. (NASDAQ:HRTX) to Announce -$0.45 EPS. Posted by admin on Apr 18th, 2022.
Three analysts have issued estimates for Heron Therapeutics' earnings. The lowest sales estimate is $21.00 million and the highest is $32.82...
It's been almost a year since my previous article on Heron Therapeutics (NASDAQ:HRTX) and while the company made progress, the stock is...
Today's big question for investors is, “what's going on with Heron Therapeutics, Inc. (NASDAQ:HRTX) stock? Its price is nose-diving -0.86 ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $34.8M | 218 | 8% | N/A |
#2 | $64.7M | 218 | 2% | N/A |
#3 | $7.5M | 218 | 17% | N/A |
#4 | $42M | 218 | 5% | N/A |
#5 | $61.2M | 219 | 8% | N/A |